Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis.

Anne K EllisDouglas P MackRémi GagnonEva HammerbySheena Gosain

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2023)

In this cost minimization analysis, the ragweed SLIT-tablet provided estimated cost savings from a public payer perspective for the treatment of ragweed ARC in Canadian children compared with SCIT or MRPATA.

Keyphrases

young adults
healthcare
mental health
emergency department
atopic dermatitis
combination therapy
data analysis
electronic health record